Reuters logo
BRIEF-Nantkwest and Nantcell announce FDA authorization for Nant Cancer vaccine clinical trials
2017年5月9日 / 中午11点39分 / 6 个月前

BRIEF-Nantkwest and Nantcell announce FDA authorization for Nant Cancer vaccine clinical trials

May 9 (Reuters) - Nantkwest Inc

* Nantkwest and nantcell announce fda authorization for the nant cancer vaccine clinical trials, the first novel combination of innate and adaptive immunotherapy in patients with pancreatic cancer Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below